부종 임상시험 시장 : 세계 산업 규모, 점유율, 동향, 기회 및 예측 - 단계별, 참가자별, 스폰서별, 유형별, 지역별, 경쟁별 세분화(2020-2030년)
Edema Clinical Trials Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Phase, By Participants, By Sponsor, By Type, By Region and Competition, 2020-2030F
상품코드:1886433
리서치사:TechSci Research
발행일:2025년 12월
페이지 정보:영문 185 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
세계의 부종 임상시험 시장은 2024년에 11억 9,000만 달러로 평가되며, 2030년까지 CAGR 4.00%로 성장하며, 15억 1,000만 달러에 달할 것으로 예측됩니다. 이 시장은 신체 조직에 체액이 비정상적으로 축적되는 부종을 관리하기 위해 개발된 신약, 치료법, 의료기기의 안전성과 유효성을 평가하는 연구에 초점을 맞추었습니다.
시장 개요
예측 기간
2026-2030년
시장 규모 : 2024년
11억 9,000만 달러
시장 규모 : 2030년
15억 1,000만 달러
CAGR : 2025-2030년
4.00%
가장 빠르게 성장하는 부문
단계 II
최대 시장
북미
주요 시장 성장 촉진요인
부종과 관련된 만성질환의 세계 부담 증가는 임상시험 시장의 주요 촉진요인입니다. 심부전, 신장병, 간경변 등의 질환의 유병률이 증가함에 따라 동반되는 부종의 발생률도 크게 증가하고 있습니다.
주요 시장 과제
종합적인 임상시험을 수행하기 위해서는 막대한 자금 투자가 필요하고, 규제 당국의 승인을 받기까지 오랜 시간이 소요되므로 세계 부종 임상시험 시장의 성장에 큰 장벽으로 작용하고 있습니다. 전임상 연구부터 임상 전 단계에 이르기까지 의약품 개발에 필요한 막대한 자본 지출은 제약사에게 큰 장벽이 되고 있습니다.
주요 시장 동향
개인 맞춤형 치료를 위한 바이오마커 활용 증가는 부종 임상시험의 중요한 동향입니다. 이 접근법은 치료에 반응할 가능성이 높은 특정 환자 하위 그룹을 식별하여 약물 개발을 촉진하고, 임상시험의 효율성과 치료 결과를 개선하는 데 도움이 됩니다.
목차
제1장 개요
제2장 조사 방법
제3장 개요
제4장 고객의 소리
제5장 세계의 부종 임상시험 시장 전망
시장 규모·예측
금액별
시장 점유율·예측
단계별(제I상, 제II상, 제III상, 제IV상)
참가자별(소아, 성인, 고령자)
스폰서별(제약회사, 학술기관, 정부기관)
유형별(전신성 부종, 국한성 부종)
지역별
기업별(2024)
시장 맵
제6장 북미의 부종 임상시험 시장 전망
시장 규모·예측
시장 점유율·예측
북미 : 국가별 분석
미국
캐나다
멕시코
제7장 유럽의 부종 임상시험 시장 전망
시장 규모·예측
시장 점유율·예측
유럽 : 국가별 분석
독일
프랑스
영국
이탈리아
스페인
제8장 아시아태평양의 부종 임상시험 시장 전망
시장 규모·예측
시장 점유율·예측
아시아태평양 : 국가별 분석
중국
인도
일본
한국
호주
제9장 중동 및 아프리카의 부종 임상시험 시장 전망
시장 규모·예측
시장 점유율·예측
중동 및 아프리카 : 국가별 분석
사우디아라비아
아랍에미리트
남아프리카공화국
제10장 남미의 부종 임상시험 시장 전망
시장 규모·예측
시장 점유율·예측
남미 : 국가별 분석
브라질
콜롬비아
아르헨티나
제11장 시장 역학
촉진요인
과제
제12장 시장 동향과 발전
합병·인수
제품 출시
최근 동향
제13장 세계의 부종 임상시험 시장 : SWOT 분석
제14장 Porter's Five Forces 분석
업계내 경쟁
신규 참여의 가능성
공급업체의 힘
고객의 힘
대체품의 위협
제15장 경쟁 구도
Otsuka Holdings Co. Ltd.
Novartis AG
Genentech, Inc.
Johnson & Johnson Services, Inc.
Merck & Co., Inc.
Sanofi S.A.
AstraZeneca plc
Bristol Myers Squibb India Pvt. Ltd.
GlaxoSmithKline plc
AbbVie Inc.
제16장 전략적 제안
제17장 조사회사 소개·면책사항
KSA
영문 목차
영문목차
The Global Edema Clinical Trials Market, valued at USD 1.19 Billion in 2024, is projected to experience a CAGR of 4.00% to reach USD 1.51 Billion by 2030. The Global Edema Clinical Trials Market focuses on research studies evaluating the safety and efficacy of novel drugs, therapies, and medical devices developed to manage edema, which involves the abnormal accumulation of fluid in body tissues.
Market Overview
Forecast Period
2026-2030
Market Size 2024
USD 1.19 Billion
Market Size 2030
USD 1.51 Billion
CAGR 2025-2030
4.00%
Fastest Growing Segment
Phase II
Largest Market
North America
Key Market Drivers
The rising global burden of edema-associated chronic diseases is a primary impetus for the clinical trials market. As the prevalence of conditions like heart failure, kidney disease, and liver cirrhosis escalates, the concurrent incidence of edema increases significantly. This expanding patient demographic urgently requires advanced therapeutic interventions. According to the World Health Organization (WHO), in a fact sheet updated May 2023, noncommunicable diseases (NCDs) accounted for 41 million deaths annually in 2021, representing 74% of all global deaths, with many NCDs directly contributing to edema.
Key Market Challenges
The considerable financial investment required for conducting comprehensive clinical trials, coupled with extended timelines for regulatory approvals, presents a substantial impediment to the growth of the Global Edema Clinical Trials Market. The extensive capital outlay necessary for drug development, encompassing preclinical research through all phases of human trials, acts as a significant barrier for pharmaceutical companies.
Key Market Trends
The increased use of biomarkers for personalized treatment is a significant trend in edema clinical trials. This approach enhances drug development by identifying specific patient subpopulations likely to respond to a therapy, thereby improving trial efficiency and therapeutic outcomes. For example, in April 2025, research identified choroidal thickness (CCT) as a crucial biomarker for diabetic macular edema, where normal CCTs correlated with better treatment responses to aflibercept.
Key Market Players
Otsuka Holdings Co. Ltd.
Novartis AG
Genentech, Inc.
Johnson & Johnson Services, Inc.
Merck & Co., Inc.
Sanofi S.A.
AstraZeneca plc
Bristol Myers Squibb India Pvt. Ltd.
GlaxoSmithKline plc
AbbVie Inc.
Report Scope:
In this report, the Global Edema Clinical Trials Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Edema Clinical Trials Market, By Phase:
Phase I
Phase II
Phase III
Phase IV
Edema Clinical Trials Market, By Participants:
Pediatrics
Adults
Geriatrics
Edema Clinical Trials Market, By Sponsor:
Pharmaceutical Companies
Academic Institutions
Government Bodies
Edema Clinical Trials Market, By Type:
Systemic Edema
Localized Edema
Edema Clinical Trials Market, By Region:
North America
United States
Canada
Mexico
Europe
France
United Kingdom
Italy
Germany
Spain
Asia Pacific
China
India
Japan
Australia
South Korea
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies presents in the Global Edema Clinical Trials Market.
Available Customizations:
Global Edema Clinical Trials Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Edema Clinical Trials Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Phase (Phase I, Phase II, Phase III, Phase IV)
5.2.2. By Participants (Pediatrics, Adults, Geriatrics)
5.2.3. By Sponsor (Pharmaceutical Companies, Academic Institutions, Government Bodies)
5.2.4. By Type (Systemic Edema, Localized Edema)
5.2.5. By Region
5.2.6. By Company (2024)
5.3. Market Map
6. North America Edema Clinical Trials Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Phase
6.2.2. By Participants
6.2.3. By Sponsor
6.2.4. By Type
6.2.5. By Country
6.3. North America: Country Analysis
6.3.1. United States Edema Clinical Trials Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Phase
6.3.1.2.2. By Participants
6.3.1.2.3. By Sponsor
6.3.1.2.4. By Type
6.3.2. Canada Edema Clinical Trials Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Phase
6.3.2.2.2. By Participants
6.3.2.2.3. By Sponsor
6.3.2.2.4. By Type
6.3.3. Mexico Edema Clinical Trials Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Phase
6.3.3.2.2. By Participants
6.3.3.2.3. By Sponsor
6.3.3.2.4. By Type
7. Europe Edema Clinical Trials Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Phase
7.2.2. By Participants
7.2.3. By Sponsor
7.2.4. By Type
7.2.5. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Edema Clinical Trials Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Phase
7.3.1.2.2. By Participants
7.3.1.2.3. By Sponsor
7.3.1.2.4. By Type
7.3.2. France Edema Clinical Trials Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Phase
7.3.2.2.2. By Participants
7.3.2.2.3. By Sponsor
7.3.2.2.4. By Type
7.3.3. United Kingdom Edema Clinical Trials Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Phase
7.3.3.2.2. By Participants
7.3.3.2.3. By Sponsor
7.3.3.2.4. By Type
7.3.4. Italy Edema Clinical Trials Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Phase
7.3.4.2.2. By Participants
7.3.4.2.3. By Sponsor
7.3.4.2.4. By Type
7.3.5. Spain Edema Clinical Trials Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Phase
7.3.5.2.2. By Participants
7.3.5.2.3. By Sponsor
7.3.5.2.4. By Type
8. Asia Pacific Edema Clinical Trials Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Phase
8.2.2. By Participants
8.2.3. By Sponsor
8.2.4. By Type
8.2.5. By Country
8.3. Asia Pacific: Country Analysis
8.3.1. China Edema Clinical Trials Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Phase
8.3.1.2.2. By Participants
8.3.1.2.3. By Sponsor
8.3.1.2.4. By Type
8.3.2. India Edema Clinical Trials Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Phase
8.3.2.2.2. By Participants
8.3.2.2.3. By Sponsor
8.3.2.2.4. By Type
8.3.3. Japan Edema Clinical Trials Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Phase
8.3.3.2.2. By Participants
8.3.3.2.3. By Sponsor
8.3.3.2.4. By Type
8.3.4. South Korea Edema Clinical Trials Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Phase
8.3.4.2.2. By Participants
8.3.4.2.3. By Sponsor
8.3.4.2.4. By Type
8.3.5. Australia Edema Clinical Trials Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Phase
8.3.5.2.2. By Participants
8.3.5.2.3. By Sponsor
8.3.5.2.4. By Type
9. Middle East & Africa Edema Clinical Trials Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Phase
9.2.2. By Participants
9.2.3. By Sponsor
9.2.4. By Type
9.2.5. By Country
9.3. Middle East & Africa: Country Analysis
9.3.1. Saudi Arabia Edema Clinical Trials Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Phase
9.3.1.2.2. By Participants
9.3.1.2.3. By Sponsor
9.3.1.2.4. By Type
9.3.2. UAE Edema Clinical Trials Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Phase
9.3.2.2.2. By Participants
9.3.2.2.3. By Sponsor
9.3.2.2.4. By Type
9.3.3. South Africa Edema Clinical Trials Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Phase
9.3.3.2.2. By Participants
9.3.3.2.3. By Sponsor
9.3.3.2.4. By Type
10. South America Edema Clinical Trials Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Phase
10.2.2. By Participants
10.2.3. By Sponsor
10.2.4. By Type
10.2.5. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Edema Clinical Trials Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Phase
10.3.1.2.2. By Participants
10.3.1.2.3. By Sponsor
10.3.1.2.4. By Type
10.3.2. Colombia Edema Clinical Trials Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Phase
10.3.2.2.2. By Participants
10.3.2.2.3. By Sponsor
10.3.2.2.4. By Type
10.3.3. Argentina Edema Clinical Trials Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Phase
10.3.3.2.2. By Participants
10.3.3.2.3. By Sponsor
10.3.3.2.4. By Type
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. Global Edema Clinical Trials Market: SWOT Analysis
